Mylan recalls 125 mcg levothyroxine tablets due to potential subpotent or superpotent drug levels. This may cause ineffective treatment or overmedication. Check NDC 51079-443-20, lot 3115893, expiring 6/2025.
Subpotent and Superpotent Drug
Mylan is recalling levothyroxine tablets that may be too weak or too strong, which could lead to ineffective treatment or overmedication. This is a serious issue for people taking thyroid medication.
The tablets may contain too little or too much active drug. This can cause treatment failure or dangerous medication levels, especially in people with thyroid conditions.
People prescribed levothyroxine by a doctor who own this specific tablet product. Those with thyroid conditions are most at risk.
Check for the NDC code 51079-443-20 on the packaging. The lot number is 3115893 and the expiration date is June 2025.
Immediately stop taking these specific levothyroxine tablets if you have them.
No, these tablets may be too weak or too strong, which could cause ineffective treatment or overmedication.
Look for NDC 51079-443-20 on the packaging, with lot number 3115893 and expiration date 6/2025.
Stop using them immediately and contact your doctor for a replacement.
We’ve drafted a message you can send Mylan to request your refund or repair — edit it as you like.
Subject: Recall D-0133-2025 — Mylan Mylan Hello, I own a Mylan that is covered by recall D-0133-2025 from Mylan. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
